You are in a "view as others" mode
Overview
ADCs, Copenhagen, Denmark.
Description
Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need.
The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen.
Founded 2017
30-50
Categories
Products
Looks like Adcendo has no published products yet.
Services
Looks like Adcendo has no published services yet.
Company reviews
Profile Strength:
undefined%
profile
completion